Patient Guide: A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 37 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06067828
Status: 🟢 Enrolling Now
Condition: Chronic Obstructive Pulmonary Disease
Phase: PHASE3

Where You Can Participate

This study is available at 37 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Tarzana, California
  • • Torrance, California
  • • And 34 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD). - Join Clinical Trial NCTNCT06067828

How to Join This Clinical Trial - NCTNCT06067828

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Obstructive Pulmonary Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Obstructive Pulmonary Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Obstructive Pulmonary Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06067828 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 37 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90095 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Tarzana, California 91356 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Torrance, California 90502 - United States

Status: RECRUITING

Clinical Research Site

Brooksville, Florida 34613 - United States

Status: RECRUITING

Clinical Research Site

Anderson, South Carolina 29621 - United States

Status: RECRUITING

Clinical Research Site

Greenville, South Carolina 29615 - United States

Status: RECRUITING

Clinical Research Site

Spartanburg, South Carolina 29303 - United States

Status: RECRUITING

Clinical Research Site

Caba, 1426 - Argentina

Status: WITHDRAWN

Clinical Research Site

Caba, C1280AEB - Argentina

Status: WITHDRAWN

Clinical Research Site

Quilmes, B1878FNR - Argentina

Status: WITHDRAWN

And 27 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Obstructive Pulmonary Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships